Mobile technology is an ever growing presence in our lives as witnessed by our addiction to our smart phones. This technology is now being heavily leveraged along with mHealth applications across all areas of pharmaceutical development. During this webinar, the presenters explored how mHealth technology can be used to reduce overall clinical development cost, while increasing subject and investigator satisfaction, retention, and engagement.

To download an archived version of the webinar, please visit our "Patient-Centric Technology for Better Trial Outcomes" webinar details page.

Our speakers for the webinar were:

			Andy Lee | Deputy Head of Clinical Sciences and Operations, Sanofi
			Glen De Vries | President, Medidata Solutions
			Randy Spaulding | Founder and President, Spaulding Clinical Research

Medidata Solutions and Spaulding Clinical Research were honored with the title of Disruptive Innovator of the Year at the Dpharm Disruptive Innovations conference on September 20, 2013 for their collaboration on a novel study evaluating the impact of mobile and cloud-based technology on patient engagement for improved health outcomes in the diabetes community. 

We encourage you to view the presentation from the meeting to see what Medidata and Spaulding Clinical are doing to transform the future of clinical trials

With the most advanced technology; the integration of monitoring, recording, analyzing and reporting all in one place; and a unique specialization in cardiac safety testing for new drugs in development, we provide the highest quality results with the most accurate data and the most efficient procedures in the industry.

At Spaulding Clinical Research, we hold ourselves to the highest standards. Passionate in our pursuit of ingenious solutions that save time and money for our clients and heroic in our ambitions to ensure the health and safety of patients, Spaulding Clinical Research strives to be the Phase I facility by which all others are measured.